home / stock / fms / fms news


FMS News and Press, Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an) From 02/24/26

Stock Information

Company Name: Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an)
Stock Symbol: FMS
Market: NYSE
Website: freseniusmedicalcare.com

Menu

Get FMS Alerts

News, Short Squeeze, Breakout and More Instantly...

FMS - Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript

2026-02-24 15:47:53 ET Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript

FMS - DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale

2026-02-03 14:09:46 ET More on DaVita, Berkshire Hathaway Inc. DaVita: Some Success Is Possible, But Volatility Is Still Heavy Berkshire Hathaway: I'm More Bullish Than Ever DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript DaVita outlines 33% EPS growth tar...

FMS - DaVita: Some Success Is Possible, But Volatility Is Still Heavy

2026-02-03 10:30:39 ET You may recall my previous article on Davita ( DVA ), when I initiated coverage and called this company a volatile "BUY", but one with a higher upside than peers. Those peers include one of my favorite investments in the entire sector, Fresenius ( FSNUY ...

FMS - Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside

2026-01-29 18:16:53 ET Despite well over 20 years of free cash flow growth, Fresenius Medical Care ( FMS ) shares have gone basically nowhere in the last 15 years on a net basis, and have only appreciated a little more than 3% a year since 2005. This is a case in point as to why low-gro...

FMS - Neutral Recommendation Issued On FMS By Goldman Sachs

2026-01-20 04:15:07 ET Goldman Sachs analyst issues NEUTRAL recommendation for FMS on January 20, 2026 09:24AM ET. FMS was trading at $21.95 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 5 - Buy, 12 - ...

FMS - Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13 16:55:57 ET Fresenius Medical Care AG (FMS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: Fresenius Medical Care AG (FMS) Presents at 44th Annual J.P. Morgan Healthcare...

FMS - Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned PR Newswire The second tranche of the share buyback is expected to be executed by May 8, 2026 The share buyback program with a total vo...

FMS - Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board PR Newswire Effective January 1, 2026 , Charles Hugh-Jones will join the Management Board as Global Chief Medical Officer As part of a planned transition Frank...

FMS - DaVita: More Volatile But Better Upside Than Fresenius

2025-12-03 09:30:33 ET I've been covering DaVita ( DVA ) as a secondary ticker for some time, next to my coverage of Fresenius Medical Care ( FMS ). It's fair to say that DVA is a peer to Fresenius, but one with a lower rate of overall credit safety, a lower dividend, and more e...

FMS - Fresenius Medical Care: 'Buy' Again Following A Peak In May

2025-11-25 10:50:40 ET When I last wrote about Fresenius Medical Care ( FMS ), it traded at less than $25/share, and I gave it a long-term fair value estimate of around $34/share, implying a significant upside. In May of 2025, when the company nearly touched $30/share, I would have ...

Previous 10 Next 10